Rubicon Research share price
Rubicon Research Ltd. · NSE: RUBICON · Healthcare
Price, one year
Price range
- Open
- ₹1,435.90
- High
- ₹1,436.00
- Low
- ₹1,390.50
- Previous close
- ₹1,436.60
- Volume
- 3.8 L
- Market cap
- ₹23,578 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 80.3
- Price to book
- 18.3
- Return on equity
- 22.4%
- EPS (TTM)
- ₹17.74
- Book value / share
- ₹77.86
- Debt to equity
- 0.20
- Revenue (TTM)
- ₹1,936 Cr
- Net profit (TTM)
- ₹288 Cr
- Sales growth, YoY
- —
- Profit growth, YoY
- —
- Operating margin
- 23.3%
- Net margin
- 14.9%
- Sales CAGR, 3 years
- —
- Profit CAGR, 3 years
- —
- Promoter holding
- 51.25%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 59.86 | 59.76 | 51.25 |
| Foreign institutions | 7.54 | 7.52 | 9.01 |
| Domestic institutions | 10.02 | 9.43 | 15.72 |
| Mutual funds | 7.14 | 7.23 | 13.78 |
| Retail and others | 2.82 | 3.46 | 3.90 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 14 Aug 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Rubicon Research today?
Rubicon Research (NSE: RUBICON) was at ₹1,424.40 on 23 Oct 2026, a change of −0.85% from the previous close.
What is the market capitalisation of Rubicon Research?
About ₹23,578 Cr at the latest price, with a P/E of 80.3, a price-to-book of 18.3, a return on equity of 22.4%. Ratios use the company's latest reported results.
Who owns Rubicon Research shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 51.25%, foreign institutions 9.01%, domestic institutions 15.72%.
Which sector and indices does Rubicon Research belong to?
NSE classifies Rubicon Research under Healthcare; it is a member of Nifty 500.
Follow Rubicon Research with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial